HomeIPSC • NASDAQ
Century Therapeutics Inc
add
$0.49
1.68%
After Hours:(1.69%)+0.0083
$0.50
Closed: Aug 29, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 7.81M | -6.03% |
Net income | -32.54M | -4.27% |
Net profit margin | — | — |
Earnings per share | -0.38 | 0.00% |
EBITDA | -31.46M | -0.54% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 155.84M | -20.65% |
Total assets | 284.69M | -31.64% |
Total liabilities | 74.79M | -61.51% |
Total equity | 209.90M | — |
Shares outstanding | 86.39M | — |
Price to book | 0.21 | — |
Return on assets | -28.87% | — |
Return on capital | -31.26% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -32.54M | -4.27% |
Cash from operations | -27.59M | -0.95% |
Cash from investing | 32.54M | 196.09% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 4.95M | 209.96% |
Free cash flow | -15.94M | -26.01% |
Previous close
$0.50
Day range
$0.49 - $0.52
Year range
$0.34 - $1.86
Market cap
43.76M USD
Avg Volume
867.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
140